eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Without publication fees

without publication fees

Open access

without publication fees
4/2020
vol. 36
 
Share:
Send email
Share:
Review paper

Non-pharmacological treatment of epilepsy

Bartosz Osuch
1
,
Piotr Maciejak
1, 2

  1. Department of Neurochemistry, Institute of Psychiatry and Neurology, Warsaw, Poland
  2. Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (4), 313–326
Online publish date: 2021/12/06
Article file
- 04R_IPiN_FARM_2020-4C_AKC.pdf  [0.22 MB]
Get citation
 
 
1. Adelson P, Peacock W, Chugani H i wsp. Temporal and ex tended temporal resections for the treatment of intracta ble seizures in early childhood. Pediatr Neurosurg 1992; 18: 169-178.
2. Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bin gaman WE. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure 2006; 15: 491-503.
3. Arora N, Mehta TR. Role of the ketogenic diet in acute neu rological diseases. Clinical Neurology and Neurosurgery 2020; 192.
4. Azevedo de Lima P, Pereira de Brito Sampaio L, Texiera Dama sceno NR. Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics (Sao Paulo) 2014; 69(10): 699-705.
5. Barzegar M, Afghan M, Tarmahi V, Behtari M, Rihimi Kha maneh S, Raeisi S. Ketogenic diet: overview, types, and pos sible anti-seizure mechanisms. Nutr Neurosci 2019; 1-10.
6. Bellebaum C, Daum I. Learning-related changes in reward expectancy are reflected in the feedback-related negativity. Eur J Neurosci 2008; 27: 1823-1835.
7. Ben-Menachem E. Neurostimulation – past, present, and beyond. Epilepsy Curr 2012; 12: 188–191.
8. Berg AT. Identification of Pharmacoresistant Epilepsy. Neu rol Clin. 2009; 27(4).
9. Boon P, Vonck K, De Herdt V, Van Dycke A, Goethals M, Goos sens L i wsp. Deep brain stimulation in patients with refrac tory temporal lobe epilepsy. Epilepsia 2007; 48(8): 1551-1560.
10. Cersosimo RO, Bartuluchi M, Fortini S, Soraru A, Pomata H, Caraballo RH. Vagus nerve stimulation: effectiveness and tol erability in 64 paediatric patients with refractory epilepsies Epileptic Disord 2011; 13: 382-388.
11. Cervenka MC, Hocker S, Koenig M, Bar B, Henry-Barron B, Kossoff EH et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology 2017; 88(10): 938-943.
12. Chen Z, Brodie MJ, Liew D, Kwan P. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Lon gitudinal Cohort Study. JAMA Neurol 2018; 75(3): 279-286.
13. Chomtho K, Suteerojntrakool O, Chomtho S. Effectiveness of Medium Chain Triglyceride Ketogenic Diet in Thai Chil dren with Intractable Epilepsy. J Med Assoc Thai 2016; 99(2): 159-165.
14. Chorągiewicz T, Żarnowska T, Gasior M, Żarnowski T. An ticonvulsant and neuroprotective effects of the ketogenic diet. Przegl Lek 2010; 67(3): 205-212.
15. Connor DE, Nixon M, Nanda A, Guthikonda B. Vagal nerve stimulation for the treatment of medically refractory epi lepsy: a review of the current literature. Neurosurg Focus 2012; 32(3).
16. Coppola G, Veggiotti P, Cusmai R, Bertoli S, Cardinali S, Di onisi-Vici C et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multi centric experience. Epilepsy Res 2002; 48(3): 221-227.
17. Cossu M, Lo Russo G, Fancione S, Mai R, Nobili L, Sartori I et al. Epilepsy surgery in children: results and predictors of outcome on seizures. Epilepsia 2008; 49: 65-72.
18. Dahlin M, Martin DA, Hedlund Z, Jonsson M, von Döbeln U, Wedell A. The ketogenic diet compensates for AGC1 deficien cy and improves myelination. Epilepsia 2015; 56(11): 176-181.
19. D’Andrea Meira I, Romao TT, Pirez do Prado HJ, Kruger LT, Paiva Pires ME, Oliviera da Conceicao P. Ketogenic diet and Epilepsy: What We Know So Far. Front Neurosci 2019; 13(5).
20. deCampo DM, Kossoff EH. Ketogenic dietary therapies for epilepsy and beyond. Curr Opin Clin Nutr Metab Care 2019; 22(4): 264-268.
21. Elliott RE, Rodgers SD, Bassani L, Morsi A, Geller EB, Carl son C et al. Vagus nerve stimulation for children withtreatment-resistant epilepsy: a consecutive series of 141 cases. J Neurosurg Pediatr 2011; 7: 491-500.
22. Engel J. Epilepsy surgery. Curr. Opin. Neurol. 1994; 7: 140–147.
23. Englot DJ, Hassnain KH, Rolston JD, Harward SC, Sinha SR, Haglund MM. Quality-of-life metrics with vagus nerve stim ulation for epilepsy from provider survey data. Epilepsy Behav 2017; 66: 4-9.
24. Fiest KM, Sajobi TT. Wiebe S. Epilepsy surgery and mean ingful improvements in quality of life: results from a ran domized controlled trial. Epilepsia 2014; 55(6): 886-892.
25. Fisher R, Salanova V, Witt T et al. SANTE Study Group: Elec trical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010; 51: 899-908.
26. Fisher RS, Velasco AL. Electrical brain stimulation for epi lepsy. Nature Reviews Neurology 2014; 10: 261-270.
27. Francis BA, Fillenworth J, Gorelick P, Karanec K, Tanner A. The feasibility, safety and effectiveness of a ketogenic diet for refractory status epilepticus in adults in the intensive care unit. Neurocrit Care 2019; 30: 652-657.
28. Gardner J. A history of deep brain stimulation: Technological innova-tion and the role of clinical assessment tools. Soc Stud Sci 2013; 43: 707-728.
29. Gulati S. Dietary Therapies: Emerging Paradigms in Therapy of Drug Resistant Epilepsy in Children : Based on 6th Dr. I. C. Verma Excellence in Research Award Oration. Indian J Pediatr 2018; 85(11): 1000-1005.
30. Guldvog B, Loyning Y, Hauglie-Hanssen E, Flood S, Bjornaes H. Surgical treatment for partial epileps among Norwegian children and adolescents. Epilepsia 1994; 35: 554-565.
31. Hallbook T, Tideman P, Rosen I, Lundgren J, Tideman E. Epilepsy surgery in children with drug-resistant epilep sy, a long-term follow-up. Acta Neurol Scand 2013; 128: 414-421.
32. Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Na ritoku DK, Tecoma ES et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998; 51: 48-55.
33. Hartman AL, Gasior M, Vining EP, Rogawski MA. Theneu ropharmacology of the ketogenic diet. Pediatr Neurol 2007; 36(5): 281-292.
34. Harvey KL, Holcomb LE, Kolwicz SC. Ketogenic Diets and Exercise Performance. Nutrients 2019; 11(10).
35. Helmers SL, Wheless JW, Frost M, Gates J, Levisohn P, Tardo C et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study J Child Neurol 2001; 16: 843-848.
36. Husari KS, Cervenka MC. The ketogenic diet all grown up-Ketogenic diet terapies for adults. Epilepsy Res. 2020.
37. Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 1971; 21(11): 1097-1103.
38. Jędrzejczak J, Majkowska-Zwolińska B, Ryglewicz D et al.Zalecenia Polskiego Towarzystwa Epileptologii dotyczące leczenia napadów padaczkowych u dorosłych. Aktualizacja. J Epileptol 2019; 27(1): 5-12 .
39. Kaczorowska B, Pawełczyk M, Przybyła M. Chirurgiczne me tody leczenia padaczki. Aktualn Neurol 2012; 12(3): 159-163.
40. Kang HC, Chung DE, Kim DW, Kim HD. Early - and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004; 4: 1116–1123.
41. Keene D, Higgins M, Ventureyra E. Outcome and life pros pects after surgical management of medically intractable epilepsy in patients under 18 years of age. Childs Nerv Syst 1997; 13: 530-535.
42. Khabbush A, Orford M, Tsai YC, Rutherford T, O’Donnell M, Eaton S et al. Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: A mechanistic insight into the medium-chain triglyceride ketogenic diet. Epilepsia 2017; 58(8): 1423-1429.
43. Kim JA, Yoon JR, Lee EJ, Lee JS, Kim JT, Kim HD et al. Effica cy of the classic ketogenic and the modified Atkinsdiets in refractory childhood epilepsy. Epilepsia 2016; 57(1): 51-8.
44. Klinger NV, Mittal S. Clinical efficacy of deep brain stimula tion for the treatment of medically refractory epilepsy. Clin Neurol Neurosurg 2016; 140: 11-25.
45. Kossoff EH, Shields WD. Nonpharmacologic care forpatients with lennox-gastaut syndrome: ketogenicdiets and vagus nerve stimulation. Epilepsia 2014; 55(4): 29-33.
46. Krishna V, Sammartino F, King NKK, So RQY, Wennberg R. Neuromodulation for epilepsy. Neurosurg Clin N Am 2016; 27: 123-131.
47. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauster WA, Ma theron G et al. Definition of Drug Resistant Epilepsy: Consensus Proposal by the Ad Hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51(6): 1069-1070.
48. Laxpati NG, Kasoff WS, Gross RE. Deep brain stimulation for the treatment of epilepsy: circuits, targets, and trials. Neurotherapeu-tics 2014; 11: 508-526.
49. Lefevre F, Aronson N. Ketogenic diet for the treatment ofre fractory epilepsy in children: a systematic review ofefficacy. Pediatrics 2000; 105(4): 46.
50. Li Z, Heber D. Ketogenic Diets. JAMA 2020; 323(4): 386.
51. Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a com parison with other ketogenic diets. Biomed J 2013; 36(1): 9-15.
52. Mahmoud SH, Ho-Huang E, Buhler J. Systematic review of ketogenic diet use in adult patients with status epilepticus. Epilepsia Open 2019; 5(1): 10-21.
53. Menachem EB, Manon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W et al. Vagus nerve stimulation for treat ment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35(3): 616-626.
54. Morrison G, Duchowny M, Resnick T, Alvarez L, Jayakar P, Prats AR et al. Epilepsy surgery in childhood. Pediatr Neu rosurg 1992; 18: 291-297.
55. Neal EG, Chaffe H, Schwartz RH, Lawson MS, EdwardsN, Fitzsimmons G et al. A randomized trial of classicaland me dium-chain triglyceride ketogenic diets in thetreatment of childhood epilepsy. Epilepsia 2009; 50(5): 1109-17.
56. Oldham MS, Horn PS, Tsevat J, Standridge S. Costs and Clinical Outcomes of Epilepsy Surgery in Children With Drug-Resistant Epilepsy. Pediatr Neurol 2015; 53(3): 216-220.
57. Park EG, Lee J. The ketogenic diet for super‐refractory status epilepticus patients in intensive care units. Brain Dev 2019; 41: 420-427.
58. Payne NE, Cross JH, Sander JW, Sisodiya SM. The ketogenic and related dietes in adolescents and adults – A review. Epi lepsia 2011; 52(11): 1941-1958.
59. Poff AM, Rho JM, A’Agostino DP. Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives. Front Neurosci 2019; 13: 1041.
60. Potasz-Kulikowska K. Wpływ głębokiej stymulacji mózgu na funkcje poznawcze i emocjonalne u chorych na epilepsję – przegląd badań. Aktualn Neurol 2017; 17(2): 87-95.
61. Prasad AN, Stafstrom CE. Dietary therapy of epilepsy in the nineties; renewed experience with the ketogenic diet. Nutrition Research 1998; 18(2): 403-416.
62. Prasoppokakorn T, Jirasakuldej S, Lakananurak N. Medi um-chain triglyceride ketogenic diet is effective for treat ment of an adult with super-refractory status epilepticus: a case report and literature review. Eur J Clin Nutr 2019; 73(12): 1594-1597.
63. Rejdak K, Rola R, Mazurkiewicz-Bełdzińska M, Halczuk I, Błaszczyk B, Rysz A et al. Diagnostyka i leczenie padaczki u osób dorosłych – rekomendacje Polskiego Towarzystwa Neu rologicznego. Polski Przegląd Neurologiczny 2016; 12(1): 15-27.
64. Rho JM. How does the ketogenic diet induce anti-seizure effects? Neurosci Lett 2017; 637: 4-10.
65. Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. The Lancet Neurology 2014; 13(11): 1114-1126 (a).
66. Ryvlin P, Gilliam FG, Nguyen DK, Colicchio G, Iudice A, Tin uper P et al. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (open prospective randomized long-term effectiveness) trial Epilepsia 2014; 55: 893-900 (b).
67. Sampaio LP. Ketogenic diet for epilepsy treatment. Arg Neu ropsiquiatr 2016; 74(10): 842-848.
68. Schaller K, Cabrilo I. Corpus callosotomy. Acta Neurochirur gica 2015; 158: 155-160.
69. Schoeler NE, Cross JH. Ketogenic dietary therapies in adults with epilepsy: a practical guide. Practical Neurology 2016; 16(3): 208-214.
70. Schoeler NE, Wood S, Aldridge V, Sander JW, Cross JH, Sisodi ya SM. Ketogenic dietary therapies for adults with epilepsy: feasibility and classification of response. Epilepsy Behav 2014; 37: 77-81.
71. Sheng J, Liu S, Qin H, Li B, Zhang X. Drug-Resistant Epilepsy and Surgery 2018; 16(1): 17-28.
72. Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol 2008; 7: 525-537.
73. Szczerbicki M, Maksymowicz W, Bacia T, Barczewska M. Chirurgiczne leczenie padaczki. Problemy Lekarskie 2006; 45(1): 27-30.
74. Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kos soff EH et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014; 82(8): 665-670.
75. Warren EC, Walker MC, Williams RSB. All You Need Is Fats for Seizure Control: Using Amoeba to Advance Epilepsy Re search. Front Cell Neurosci 2018; 12: 199.
76. West S, Nolan SJ, Newton R. Surgery for epilepsy:a systematic review of current evidence. Epileptic Disord. 2016; 18(2): 113-121.
77. Wheless JW, Gienapp AJ, Ryvlin P. Vagus nerve stimulation (VNS) therapy update. Epilepsy Behav. 2018; 88: 2-10.
78. Wiebe S., Blume W.T., Girvin J.P., Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N. Engl. J. Med. 2001; 345(5): 311-318.
79. Wilder RM. High fat diets in epilepsy. Mayo Clin. Bull. 1921; 2: 308.
80. Winesett SP, Kordecki Bessone S, Kossof EHW. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert review of neurotherapeutics 2015; 15(6): 621-628.
81. Wyllie E, Comair YG, Kotagal P, Bulacio J, Bing-Aman W, Rug gieri P. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 1998; 44: 740-748.
82. Xue-Ping W, Hai-Jiao W, Li-Na Z, Xu D, Ling L. Risk Fac tors for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2019; 98(30): 16402.
83. Youngosn NA, Morris MJ, Ballard WO. The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metab olism-altering drugs. Seizure 2017; 52: 15-19.

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.